AZYRADA

Serial Number 90739249
721

Registration Progress

Application Filed
May 27, 2021
Under Examination
May 17, 2022
Approved for Publication
Mar 22, 2022
Published for Opposition
Mar 22, 2022
Registered

Trademark Image

AZYRADA

Basic Information

Serial Number
90739249
Filing Date
May 27, 2021
Published for Opposition
March 22, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
721
Status Date
Apr 25, 2024
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-219

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Richard A. Friedman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description
Apr 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2024 EX4G S SOU EXTENSION 4 GRANTED
Apr 25, 2024 EXT4 S SOU EXTENSION 4 FILED
Apr 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 6, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2023 EX3G S SOU EXTENSION 3 GRANTED
Oct 4, 2023 EXT3 S SOU EXTENSION 3 FILED
Oct 4, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 13, 2023 EX2G S SOU EXTENSION 2 GRANTED
Apr 13, 2023 EXT2 S SOU EXTENSION 2 FILED
Apr 13, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 28, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 28, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 28, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2022 EX1G S SOU EXTENSION 1 GRANTED
Oct 17, 2022 EXT1 S SOU EXTENSION 1 FILED
Oct 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
May 17, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 22, 2022 PUBO A PUBLISHED FOR OPPOSITION
Mar 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2022 DOCK D ASSIGNED TO EXAMINER
Aug 23, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 31, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Anti-inflammatory preparations; Pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis

Classification

International Classes
005